Shachar Michal, Cohen Smadar
Department of Biotechnology Engineering and The Institute for Applied Biosciences, Ben-Gurion University of the Negev, Beer Sheva, 84105, Israel.
Heart Fail Rev. 2003 Jul;8(3):271-6. doi: 10.1023/a:1024729919743.
Cardiac tissue engineering has emerged as a promising approach to replace or support an infarcted cardiac tissue and thus may hold a great potential to treat and save the lives of patients with heart diseases. By its broad definition, tissue engineering involves the construction of tissue equivalents from donor cells seeded within 3-D biomaterials, then culturing and implanting the cell-seeded scaffolds to induce and direct the growth of new, healthy tissue. In this review, we present an up-to-date summary of the research in cardiac tissue engineering, with an emphasis on the design principles and selection criteria that have been used in two key technologies employed in tissue engineering, (1) biomaterials technology, for the creation of 3-D porous scaffolds which are used to support and guide the tissue formation from dissociated cells, and (2) bioreactor cultivation of the 3-D cell constructs during ex-vivo tissue engineering, which aims to duplicate the normal stresses and flows experienced by the tissues.
心脏组织工程已成为一种有前景的方法,用于替代或支持梗死的心脏组织,因此在治疗和挽救心脏病患者生命方面可能具有巨大潜力。从广义上讲,组织工程涉及从接种在三维生物材料中的供体细胞构建组织等效物,然后培养并植入接种细胞的支架,以诱导和引导新的健康组织生长。在本综述中,我们提供了心脏组织工程研究的最新总结,重点关注组织工程中两项关键技术所采用的设计原则和选择标准,(1)生物材料技术,用于创建三维多孔支架,以支持和引导解离细胞形成组织;(2)体外组织工程过程中三维细胞构建体的生物反应器培养,旨在模拟组织所经历的正常应力和流动。